DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,583,831 | -8.4% | 61,769 | 0.0% | 1.32% | -7.2% |
| Q2 2023 | $14,824,560 | -4.8% | 61,769 | 0.0% | 1.42% | -12.5% |
| Q1 2023 | $15,568,259 | -5.0% | 61,769 | 0.0% | 1.63% | -6.6% |
| Q4 2022 | $16,394,728 | +2.8% | 61,769 | 0.0% | 1.74% | -10.4% |
| Q3 2022 | $15,954,000 | +1.9% | 61,769 | 0.0% | 1.94% | -5.9% |
| Q2 2022 | $15,660,000 | -13.6% | 61,769 | 0.0% | 2.07% | +13.5% |
| Q1 2022 | $18,119,000 | -15.5% | 61,769 | -5.2% | 1.82% | -22.3% |
| Q4 2021 | $21,430,000 | +22.6% | 65,135 | 0.0% | 2.34% | +9.3% |
| Q2 2021 | $17,480,000 | +19.2% | 65,135 | 0.0% | 2.14% | +8.7% |
| Q1 2021 | $14,661,000 | +1.3% | 65,135 | 0.0% | 1.97% | -7.0% |
| Q4 2020 | $14,469,000 | +3.2% | 65,135 | 0.0% | 2.12% | -10.0% |
| Q3 2020 | $14,026,000 | +21.8% | 65,135 | 0.0% | 2.36% | +6.0% |
| Q2 2020 | $11,518,000 | +27.8% | 65,135 | 0.0% | 2.22% | +15.5% |
| Q1 2020 | $9,015,000 | -9.8% | 65,135 | 0.0% | 1.92% | +9.1% |
| Q4 2019 | $9,997,000 | +6.3% | 65,135 | 0.0% | 1.76% | -9.3% |
| Q3 2019 | $9,407,000 | +1.1% | 65,135 | 0.0% | 1.94% | -4.5% |
| Q2 2019 | $9,309,000 | +8.3% | 65,135 | 0.0% | 2.04% | +6.8% |
| Q1 2019 | $8,599,000 | +28.0% | 65,135 | 0.0% | 1.90% | +22.4% |
| Q4 2018 | $6,717,000 | -5.1% | 65,135 | 0.0% | 1.56% | -5.6% |
| Q3 2018 | $7,078,000 | +10.1% | 65,135 | 0.0% | 1.65% | -1.3% |
| Q2 2018 | $6,428,000 | +0.8% | 65,135 | 0.0% | 1.67% | -0.3% |
| Q1 2018 | $6,377,000 | +5.5% | 65,135 | 0.0% | 1.67% | +6.6% |
| Q4 2017 | $6,046,000 | +8.2% | 65,135 | 0.0% | 1.57% | -4.1% |
| Q3 2017 | $5,587,000 | +1.6% | 65,135 | 0.0% | 1.64% | -4.9% |
| Q2 2017 | $5,497,000 | +7.4% | 65,135 | +8.9% | 1.72% | +16.3% |
| Q1 2017 | $5,118,000 | +9.9% | 59,835 | 0.0% | 1.48% | +5.0% |
| Q4 2016 | $4,658,000 | -0.7% | 59,835 | 0.0% | 1.41% | +14.3% |
| Q3 2016 | $4,690,000 | +2.4% | 59,835 | 0.0% | 1.24% | +9.7% |
| Q2 2016 | $4,580,000 | – | 59,835 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |